CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 53 filers reported holding CYTOSORBENTS CORP in Q3 2023. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $764,000 | -31.4% | 349,000 | 0.0% | 0.01% | -11.1% |
Q1 2022 | $1,113,000 | +5.8% | 349,000 | +39.0% | 0.01% | +12.5% |
Q4 2021 | $1,052,000 | -33.9% | 251,000 | +28.1% | 0.01% | -33.3% |
Q3 2021 | $1,592,000 | +54.0% | 196,000 | +43.1% | 0.01% | +71.4% |
Q2 2021 | $1,034,000 | -13.0% | 137,000 | 0.0% | 0.01% | -12.5% |
Q1 2021 | $1,189,000 | +8.9% | 137,000 | 0.0% | 0.01% | -11.1% |
Q4 2020 | $1,092,000 | -0.1% | 137,000 | 0.0% | 0.01% | -25.0% |
Q3 2020 | $1,093,000 | -5.6% | 137,000 | +17.1% | 0.01% | -7.7% |
Q2 2020 | $1,158,000 | +136.8% | 117,000 | +84.8% | 0.01% | +85.7% |
Q1 2020 | $489,000 | – | 63,312 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sargent Investment Group, LLC | 964,141 | $7,829,000 | 1.90% |
Skylands Capital, LLC | 1,837,541 | $14,921,000 | 1.84% |
CM Management, LLC | 175,000 | $1,421,000 | 1.06% |
Soleus Capital Management, L.P. | 800,000 | $6,496,000 | 1.01% |
Avenir Corp | 1,395,385 | $11,331,000 | 0.95% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 185,000 | $1,502,000 | 0.55% |
Winning Points Advisors, LLC | 86,200 | $701,000 | 0.51% |
Granahan Investment Management | 1,154,561 | $9,375,000 | 0.18% |
SECTORAL ASSET MANAGEMENT INC | 244,660 | $1,987,000 | 0.16% |
Redmile Group, LLC | 1,044,434 | $8,481,000 | 0.15% |